Market Size of Netherlands Cardiovascular Devices Industry
| Study Period | 2019-2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 686.27 Million |
| Market Size (2029) | USD 900.33 Million |
| CAGR (2024 - 2029) | 5.58 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Netherlands Cardiovascular Devices Market Analysis
The Netherlands Cardiovascular Devices Market size is estimated at USD 686.27 million in 2024, and is expected to reach USD 900.33 million by 2029, growing at a CAGR of 5.58% during the forecast period (2024-2029).
The COVID-19 pandemic impacted the growth of the Netherlands' cardiovascular devices market. For instance, an article published by the Netherlands Heart Journal in February 2021 reported that an online survey was conducted among the four Dutch hospitals, which reported a 25.7% reduction in cardiac surgeries from April 2020 to July 2020, as compared to the previous year. Thus, the reduction in cardiac surgery in many hospitals in the Netherlands reduced the demand for cardiovascular devices, thereby impacting the growth of the studied market. However, in the current scenario, it is anticipated that the reduction in COVID-19 cases has led to the ease of government restriction. As a result, the resumption of cardiovascular surgical procedures may increase the demand for cardiovascular devices over the forecast period.
The major factors driving the growth of the studied market in the Netherlands are due to increasing cases of cardiovascular diseases, and technological developments. A report published by the European Survey of Cardiovascular Diseases in July 2022 reported that 36% of 18–34-year-olds recognized high cholesterol as a risk factor, compared with over twice as many of those aged above 55 years. A high percentage of the young population in the Netherlands are living with high cholesterol, which may increase the risk of heart diseases like heart attack, which may increase the demand for heart surgeries.
Similarly, another article published by the European Call for Innovative Treatments in Cardiovascular Diseases (CARDINNOV) in January 2023 reported that in the Netherlands, there are about 1.5 million people with chronic cardiovascular disease. These are all conditions that affect the heart and/or blood vessels. Thus, such instances may lead to increased demand for cardiovascular devices in the country.
Furthermore, the technological development procedures are also driving the growth of the studied market. For instance, in October 2022, AMT Medical, a clinical-stage medical device company based in the Netherlands, showed a promising result for the ELANA Heart Bypass Solution. Thus, such developments are driving the growth of the studied market.
Thus, due to the increasing cases of cardiovascular diseases and technological developments, the studied market is expected to witness high growth over the forecast period. However, stringent regulatory policies and the high cost of instruments and procedures may slow down the growth of the studied market.
